title: Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis.
abstract: Psoriatic arthritis (PsA) is a chronic and erosive form of arthritis of unknown cause. We aimed to characterize the PsA phenotype using gene expression profiling and comparing it with healthy control subjects and patients rheumatoid arthritis (RA). Peripheral blood cells (PBCs) of 19 patients with active PsA and 19 age- and sex-matched control subjects were used in the analyses of PsA, with blood samples collected in PaxGene tubes. A significant alteration in the pattern of expression of 313 genes was noted in the PBCs of PsA patients on Affymetrix U133A arrays: 257 genes were expressed at reduced levels in PsA, and 56 genes were expressed at increased levels, compared with controls. Downregulated genes tended to cluster to certain chromosomal regions, including those containing the psoriasis susceptibility loci PSORS1 and PSORS2. Among the genes with the most significantly reduced expression were those involved in downregulation or suppression of innate and acquired immune responses, such as SIGIRR, STAT3, SHP1, IKBKB, IL-11RA, and TCF7, suggesting inappropriate control that favors proin-flammatory responses. Several members of the MAPK signaling pathway and tumor suppressor genes showed reduced expression. Three proinflammatory genes--S100A8, S100A12, and thioredoxin--showed increased expression. Logistic regression and recursive partitioning analysis determined that one gene, nucleoporin 62 kDa, could correctly classify all controls and 94.7% of the PsA patients. Using a dataset of 48 RA samples for comparison, the combination of two genes, MAP3K3 followed by CACNA1S, was enough to correctly classify all RA and PsA patients. Thus, PBC gene expression profiling identified a gene expression signature that differentiated PsA from RA, and PsA from controls. Several novel genes were differentially expressed in PsA and may prove to be diagnostic biomarkers or serve as new targets for the development of therapies.
authors.affiliation: Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, Manhasset, NY 11030, USA.
authors.forename: Franak M
authors.initials: FM
authors.lastname: Batliwalla
authors.forename: Wentian
authors.initials: W
authors.lastname: Li
authors.forename: Christopher T
authors.initials: CT
authors.lastname: Ritchlin
authors.forename: Xiangli
authors.initials: X
authors.lastname: Xiao
authors.forename: Max
authors.initials: M
authors.lastname: Brenner
authors.forename: Teresina
authors.initials: T
authors.lastname: Laragione
authors.forename: Tianmeng
authors.initials: T
authors.lastname: Shao
authors.forename: Robert
authors.initials: R
authors.lastname: Durham
authors.forename: Sunil
authors.initials: S
authors.lastname: Kemshetti
authors.forename: Edward
authors.initials: E
authors.lastname: Schwarz
authors.forename: Rodney
authors.initials: R
authors.lastname: Coe
authors.forename: Marlena
authors.initials: M
authors.lastname: Kern
authors.forename: Emily C
authors.initials: EC
authors.lastname: Baechler
authors.forename: Timothy W
authors.initials: TW
authors.lastname: Behrens
authors.forename: Peter K
authors.initials: PK
authors.lastname: Gregersen
authors.forename: Pércio S
authors.initials: PS
authors.lastname: Gulko
mesh_terms: D000328:Adult; D015535:Arthritis, Psoriatic / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D007962:Leukocytes / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D020411:Oligonucleotide Array Sequence Analysis